Loading your page…
Marketing-authorisation holder · Cyprus
132 medicines in 4 countries, as authorisation holder and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
1–25 of 132
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACICLOVIR NORIDEMPolvere per soluzione per infusione endovenosa | Aciclovir | Italy | Authorised | |
| Aciclovir Noridem 250 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Aciclovir | Netherlands | Authorised | 2022 |
| ACICLOVIR NORIDEM 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG250 mg · Polvo para solución para perfusión | Aciclovir | Spain | Marketed | 2023 |
| Aciclovir Noridem 500 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Aciclovir | Netherlands | Authorised | 2022 |
| ACICLOVIR NORIDEM 500 MG POLVO PARA SOLUCION PARA PERFUSION EFG500 mg · Polvo para solución para perfusión | Aciclovir | Spain | Marketed | 2023 |
| Aciklovir Noridem 250 mg prašak za otopinu za infuzijuprašak za otopinu za infuziju | Aciclovir | Croatia | Not marketed | 2022 |
| Aciklovir Noridem 500 mg prašak za otopinu za infuzijuprašak za otopinu za infuziju | Aciclovir | Croatia | Not marketed | 2022 |
| ACQUA PER PREPARAZIONI INIETTABILI NORIDEMSolvente per uso parenterale | Acqua preparazioni iniettabili | Italy | Authorised | |
| Adrenaline Noridem 1 mg/ml oplossing voor injectieOplossing voor injectie | Epinephrine | Netherlands | Authorised | 2025 |
| AMIKACINA NORIDEMSoluzione iniettabile o per infusione | Amikacin | Italy | Authorised | |
| AMIKACINA NORIDEM 125 MG/ML SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG166,88 mg · Solución inyectable y para perfusión | Amikacin | Spain | Authorised | 2025 |
| AMIKACINA NORIDEM 250 MG/ML SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG333,75 mg · Solución inyectable y para perfusión | Amikacin | Spain | Authorised | 2025 |
| Ampicilin Noridem 0,5 g prašak za otopinu za injekciju / infuzijuPrašak za otopinu za injekciju / infuziju | Ampicillin | Croatia | Not marketed | 2025 |
| Ampicilin Noridem 1 g prašak za otopinu za injekciju / infuzijuPrašak za otopinu za injekciju / infuziju | Ampicillin | Croatia | Not marketed | 2025 |
| Ampicilin Noridem 2 g prašak za otopinu za injekciju / infuzijuPrašak za otopinu za injekciju / infuziju | Ampicillin | Croatia | Not marketed | 2025 |
| AMPICILINA NORIDEM 1 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG1063 mg · Polvo para solución inyectable y para perfusión | Ampicillin | Spain | Authorised | 2026 |
| AMPICILINA NORIDEM 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG2126 mg · Polvo para solución inyectable y para perfusión | Ampicillin | Spain | Authorised | 2026 |
| AMPICILINA NORIDEM 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG531 mg · Polvo para solución inyectable y para perfusión | Ampicillin | Spain | Authorised | 2026 |
| ATROPINA NORIDEM 1 MG/ML SOLUCION INYECTABLE EFG1 mg/ml · Solución inyectable | Atropine | Spain | Authorised | 2025 |
| ATROPINA SOLFATO NORIDEMSoluzione iniettabile | Atropine | Italy | Authorised | |
| Benzilpenicilinnatrij Noridem 1 MIU prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Penicillin | Croatia | Not marketed | 2025 |
| Benzilpenicilinnatrij Noridem 10 MIU prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Penicillin | Croatia | Not marketed | 2025 |
| Benzilpenicilinnatrij Noridem 2 MIU prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Penicillin | Croatia | Not marketed | 2025 |
| Benzilpenicilinnatrij Noridem 5 MIU prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Penicillin | Croatia | Not marketed | 2025 |
| CEFAZOLINA NORIDEMPolvere per soluzione iniettabile/per infusione | Cefazolin | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 47 | 47 | 0 | CompaniesAll medicines |
| Spain | 40 | 40 | 0 | CompaniesAll medicines |
| Italy | 35 | 35 | 0 | CompaniesAll medicines |
| Croatia | 10 | 10 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
